Xiamen Baorui Pharmaceutical

Xiamen Baorui Pharmaceutical is a pharmaceutical company based in Xiamen, China, and a wholly-owned subsidiary of the Xiamen Kingdomway Group. The company specializes in the research, development, and manufacturing of chemical drugs, focusing on both Active Pharmaceutical Ingredients (APIs) and finished dosage forms. Its therapeutic portfolio primarily targets cardiovascular diseases, metabolic disorders, and infectious diseases, with key products including Rosuvastatin and Entecavir. Baorui operates advanced GMP-certified facilities and provides contract manufacturing and development services (CDMO) to international partners. The company plays a strategic role in Kingdomway's expansion into the broader healthcare and pharmaceutical markets.